发明名称 |
NOVEL HEMOGLOBIN-DERIVED PEPTIDE BASED PHARMACEUTICAL COMPOSITIONS |
摘要 |
The present invention relates to a pharmaceutical composition comprising at least one Toll-like receptor (TLR)-activating amphiphilic lipid and at least one hemoglobin-derived peptide and optionally a pharmaceutically acceptable carrier. The present invention also relates to the pharmaceutical composition according to the invention for use in preventing and/or treating tumours, preventing and/or treating infections, preventing and/or treating allergies, preventing and/or treating age-related immune imbalances, stimulating the innate and adaptive immune system and/or alleviating the adverse side effects of irradiation. Moreover, the present invention also relates to a hemoglobin-derived peptide as well as its use in treating a bacterial infection. |
申请公布号 |
EP2983698(A1) |
申请公布日期 |
2016.02.17 |
申请号 |
EP20140724002 |
申请日期 |
2014.04.11 |
申请人 |
CLINIQUE LA PRAIRIE |
发明人 |
HEINI, ADRIAN;RIETSCHEL, ERNST THEODOR;ALEXANDER, CHRISTIAN;BRANDENBURG, KLAUS;ULMER, ARTUR J.;MACH, JEAN-PIERRE;GORCZYNSKI, REGINALD M.;HEUMANN, DIDIER |
分类号 |
A61K38/42;A61K31/739;A61P31/04;C07K14/805 |
主分类号 |
A61K38/42 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|